Nevolat vs. Saxenda: What the UK launch of this new weight loss injection means for you
With the UK launch of Nevolat — commonly referred to as a “generic Saxenda” — the conversation around affordable, accessible weight loss treatments is evolving. But what does the arrival of Nevolat mean for patients, and how does it compare to existing options like weekly GLP-1 injections?
Why are generics like Nevolat being released?
Generic medications play a vital role in healthcare, offering the same active ingredient as branded drugs but typically at a lower cost. Nevolat provides a new, more cost-effective way to access the active ingredient liraglutide, the same as Saxenda, a licensed weight loss injection used daily.
As Saxenda’s patent protection has ended, manufacturers are now able to produce clinically equivalent versions like Nevolat — subject to the same MHRA regulatory standards.

How it works

We'll provide you with a tailored treatment plan from a UK registered doctor

Receive genuine medication shipped discreetly to your door